Pulmonary arterial hypertension in Latin America: epidemiological data from local studies
Author:
Funder
GlaxoSmithKline foundation
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12890-018-0667-8.pdf
Reference36 articles.
1. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries. Chest. 2011;139(1):128–37. https://doi.org/10.1378/chest.10-0075 . PubMed PMID: 20558556
2. Jiang X, Jing ZC. Epidemiology of pulmonary arterial hypertension. Curr Hypertens Rep. 2013;15(6):638–49. https://doi.org/10.1007/s11906-013-0397-5 . PubMed PMID: 24114080
3. Humbert M, Khaltaev N, Bousquet J, Souza R. Pulmonary hypertension - from an orphan disease to a public health problem. Chest. 2007;132(2):365–7. https://doi.org/10.1378/chest.07-0903 . PubMed PMID: WOS:000248779700002
4. McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of Pulmonary Arterial Hypertension. J Am Coll Cardiol. 2015;65(18):1976–97. https://doi.org/10.1016/j.jacc.2015.03.540
5. Hoeper MM, Simon RGJ. The changing landscape of pulmonary arterial hypertension and implications for patient care. Eur Respir Rev. 2014;23(134):450–7. https://doi.org/10.1183/09059180.00007814 . PubMed PMID: 25445943
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sexual function, health functionality, and quality of life in females with pulmonary arterial hypertension: a cross-sectional study;The Journal of Sexual Medicine;2024-08-05
2. Pulmonary hypertension;Nature Reviews Disease Primers;2024-01-04
3. Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension;Current Vascular Pharmacology;2023-12-19
4. Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group;Pulmonary Circulation;2023-10
5. Risk stratification, prognosis, and survival in a pulmonary arterial hypertension cohort in Latin America. A multicenter study;Respiratory Medicine and Research;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3